Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01600924Active Not Recruiting

Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes

Role: lead

NCT02421393Not ApplicableCompleted

Study to Weigh the Effect of Exercise Training on BONE (SWEET-BONE) Quality and Strength in Type 2 Diabetes

Role: lead

NCT03278704Not ApplicableTerminated

Concurrent Training in Type 2 Diabetes

Role: collaborator

NCT01600937Not ApplicableCompleted

Italian Diabetes and Exercise Study 2

Role: lead

All 4 trials loaded